DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the METROPOLIS HEALTHCARE LTD (METROPOLIS) share price today?

METROPOLIS HEALTHCARE LTD (METROPOLIS) is trading at ₹545.3 on the NSE, down 5.73% on the day. Source: DocStoX.

What is the PE ratio of METROPOLIS HEALTHCARE LTD?

METROPOLIS HEALTHCARE LTD has a price-to-earnings (PE) ratio of 59.5 in the Healthcare sector.

What is the market capitalisation of METROPOLIS HEALTHCARE LTD?

METROPOLIS HEALTHCARE LTD has a market capitalisation of approximately ₹11,323 crore.

METROPOLIS HEALTHCARE LTD

METROPOLIS·NSE·Healthcare

₹545.30▼ -33.15 (-5.73%)

Healthcare · Healthcare Service Provider

A steady, established business

Day₹540.05

₹583.35

52W₹411

₹22637%

Open

₹580.85

High

₹583.35

Low

₹540.05

Prev Close

₹578.45

Volume

3.25L

VWAP

₹556.12

Snapshot

Key fundamentals

Market Cap

₹11,323 Cr

P/E Ratio

59.47Expensive

P/B Ratio

7.46

EPS

₹9.17

Book Value

₹73.00

ROE

13.80%Average

ROCE

18.00%Decent

Dividend Yield

0.89%

Debt / Equity

0.15Low

Face Value

₹2.00

52W High

₹2263.00

52W Low

₹411.44

Sector

Healthcare

Industry

Healthcare Service Provider

Avoid

Narrow moatHigh uncertainty

Fair value estimate

₹89

▼ 83.6%downside

Trading at ₹545 — 84% above our estimate

BearFair valueBull

₹76₹89₹123

/100

Business quality — Watch the fundamentals

Growth 46Profitability 49Efficiency 25Valuation 46

Plain English

Our view

A steady, established business
Low debt relative to equity
Fundamental red flags (Piotroski 3/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

59.5Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

13.8%Average

Above 15% is considered healthy for Indian equities

ROCE

18.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.15Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹11,323 Cr

P/B

7.46

EPS

₹9.17

Div Yield

0.89%

What changed

Recent changes

Foreign investors-0.3% stake last quarter
Domestic institutions+2.9% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 59.5×

Growth

Steady

+13% rev CAGR

Profitability

Healthy

13.8% ROE

Financial health

Rock solid

D/E 0.15

Momentum

N/A

No technicals

Today

Trading activity

Delivery %52.1%

Turnover₹1807.78L Cr

Trades18,545

VWAP₹556.12

Face value₹2.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+12.8%

+10.5%

10Y

+13.2%

Profit

+10.1%

+0.9%

10Y

+8.8%

EPS

+9.5%

+0.5%

10Y

-7.5%

Profile

Cons

Stock is trading at 7.78 times its book value
The company has delivered a poor sales growth of 10.5% over past five years.
Company has a low return on equity of 12.6% over last 3 years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 0.34 pts; domestic institutions added 2.87 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

49%

Promoter

Promoters

48.9%-0.01

Public

4.9%-2.51

FII / FPI

10.4%-0.34

DII

35.8%+2.87

Total shareholders

48,488

Quarterly trend

Ownership over time

Q4 FY26

Promoter48.86%

FII10.43%

DII35.80%

Public4.92%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.